Queen's University Belfast is proud to be hosting the joint INBIONET/Infect-ERA Conference over 14-15 September 2016.
This conference will be the final conference of the EU funded INBIONET Programme and the final seminar for the first joint call of Infect-ERA and mid-term seminar of the second call of the Infect-ERA Programme. Delegates attending this conference will contribute to discussions on some of the most deadly infectious diseases and will present the latest findings to shape future treatments of infection.
The INBIONET programme is funded under the Marie Curie Initial Training Network scheme (ITN) as part of the EU's Seventh Framework Programme (FP7). This programme is at the interface between microbiology, immunology and cellular biology and aims to explore some of the most novel themes that are beginning to emerge in the mechanisms by which pathogens manipulate host defence responses. This Network integrates seven academic groups internationally recognized in the fields of microbial pathogenesis, innate immunity and molecular recognition together with intensive research SME, Preclin Biosystems and a multinational pharmaceutical company, Sanofi-Aventis. During the duration of this project a total of 15 fellows have received training in all areas of infection biology research.
Infect-ERA is an ERA-NET on human infectious diseases which is also funded under FP7. This consortium consists of 14 funding organisations from 11 countries. Infect-ERA aims to fund high quality and cutting edge transnational and translational research bringing together basic, applied, technology-driven and clinical research approaches to a broad variety of topics of human infectious diseases. Infect-ERA is also supporting the development of early scientists career by dedicated a part of the call budget to young scientist consortia and organizing networking events. In addition to monitor the progress of the project funded under the first and second joint transnational call of Infect-ERA, this conference will allow networking young scientists from Infect-ERA projects with the INBIONET fellows.